Taneja SS - Search Results

1

Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials.

Wang AZ, Lebastchi AH, O'Connor LP, Ahdoot M, Mehralivand S, Yerram N, Taneja SS, George AK, Sanchez-Salas R, Ward JF, Laguna P, de la Rosette J, Pinto PA. Wang AZ, et al. Among authors: taneja ss. World J Urol. 2021 Mar;39(3):729-739. doi: 10.1007/s00345-020-03525-0. Epub 2021 Jan 2. World J Urol. 2021. PMID: 33388878 Review.

2

Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.

Taneja SS, Tran K, Lepor H. Taneja SS, et al. Urology. 2001 Aug;58(2):222-7. doi: 10.1016/s0090-4295(01)01229-8. Urology. 2001. PMID: 11489705

3

Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels.

Lefkowitz GK, Taneja SS, Brown J, Melamed J, Lepor H. Lefkowitz GK, et al. Among authors: taneja ss. J Urol. 2002 Oct;168(4 Pt 1):1415-8. doi: 10.1016/S0022-5347(05)64463-1. J Urol. 2002. PMID: 12352407

4

Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.

Naya Y, Fritsche HA, Cheli CD, Stamey TA, Bartsch G, Brawer MK, Childs S, Taneja SS, Lepor H, Partin AW, Sokoll LJ, Chan DW, Babaian RJ. Naya Y, et al. Among authors: taneja ss. Urology. 2003 Dec;62(6):1058-62. doi: 10.1016/j.urology.2003.07.016. Urology. 2003. PMID: 14665355

5

Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.

Shen S, Lepor H, Yaffee R, Taneja SS. Shen S, et al. Among authors: taneja ss. J Urol. 2005 Mar;173(3):777-80. doi: 10.1097/01.ju.0000153619.33446.60. J Urol. 2005. PMID: 15711268

6

Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy.

Patel R, Lepor H, Thiel RP, Taneja SS. Patel R, et al. Among authors: taneja ss. Urology. 2005 May;65(5):942-6. doi: 10.1016/j.urology.2004.12.013. Urology. 2005. PMID: 15882728

7

Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progression.

Osman I, Mikhail M, Shuch B, Clute M, Cheli CD, Ghani F, Thiel RP, Taneja SS. Osman I, et al. Among authors: taneja ss. J Urol. 2005 Dec;174(6):2174-7. doi: 10.1097/01.ju.0000181205.23233.65. J Urol. 2005. PMID: 16280758

8

Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s.

Berger AD, Satagopan J, Lee P, Taneja SS, Osman I. Berger AD, et al. Among authors: taneja ss. Urology. 2006 Jan;67(1):120-4. doi: 10.1016/j.urology.2005.08.005. Urology. 2006. PMID: 16413346

9

Obesity and prostate cancer.

O'Malley RL, Taneja SS. O'Malley RL, et al. Among authors: taneja ss. Can J Urol. 2006 Apr;13 Suppl 2:11-7. Can J Urol. 2006. PMID: 16672123 Review.

10

Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery.

Dash A, Lee P, Zhou Q, Jean-Gilles J, Taneja S, Satagopan J, Reuter V, Gerald W, Eastham J, Osman I. Dash A, et al. Urology. 2008 Sep;72(3):641-6. doi: 10.1016/j.urology.2007.11.024. Epub 2008 Mar 4. Urology. 2008. PMID: 18295314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters